| Serial Number | 87718255 |
| Word Mark | TABMELT |
| Filing Date | Tuesday, December 12, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, December 19, 2025 |
| Registration Number | 5771628 |
| Registration Date | Tuesday, June 4, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable tablets that facilitate the delivery of pharmaceutical preparations; Nutraceuticals for use as a dietary supplement; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the endocrine system, the digestive system, the excretory system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, the respiratory system, and/or the skeletal system; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Vaccine preparations; Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for the endocannabinoid; Human vaccine preparations; Oral vaccine preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents |
| Pseudo Mark | TAB MELT |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 19, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, January 3, 2018 |
| First Use In Commerce Date | Saturday, May 5, 2018 |
| Party Name | Sentar Pharmaceuticals |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92614 |
| Party Name | Sentar Pharmaceuticals |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92614 |
| Event Date | Event Description |
| Friday, December 15, 2017 | NEW APPLICATION ENTERED |
| Friday, December 22, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 22, 2018 | ASSIGNED TO EXAMINER |
| Thursday, March 22, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, March 22, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, March 22, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 20, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 2, 2018 | ASSIGNED TO LIE |
| Wednesday, October 10, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 10, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 30, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 30, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 30, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 17, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, January 17, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, April 19, 2019 | TEAS AMENDMENT OF USE RECEIVED |
| Saturday, April 20, 2019 | USE AMENDMENT FILED |
| Saturday, April 20, 2019 | AMENDMENT TO USE PROCESSING COMPLETE |
| Friday, April 19, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 19, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, April 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 19, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 19, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 24, 2019 | USE AMENDMENT ACCEPTED |
| Wednesday, April 24, 2019 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Thursday, April 25, 2019 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Tuesday, April 30, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 30, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 30, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 30, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, June 4, 2019 | REGISTERED-SUPPLEMENTAL REGISTER |
| Monday, June 6, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 6, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 6, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 25, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Tuesday, July 25, 2023 | WITHDRAWAL OF ATTORNEY GRANTED |
| Friday, December 19, 2025 | CANCELLED SEC. 8 (6-YR) |